Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biological Specimen Banks | 10 | 2018 | 784 | 2.850 |
Why?
|
Genetic Research | 10 | 2017 | 172 | 2.670 |
Why?
|
Genomics | 37 | 2024 | 5795 | 2.640 |
Why?
|
Neonatal Screening | 16 | 2024 | 595 | 2.490 |
Why?
|
Parents | 23 | 2023 | 3549 | 2.450 |
Why?
|
Genetic Testing | 31 | 2024 | 3531 | 2.250 |
Why?
|
Informed Consent | 10 | 2018 | 1005 | 1.550 |
Why?
|
Genome | 8 | 2023 | 1739 | 1.270 |
Why?
|
Information Dissemination | 8 | 2018 | 1131 | 1.220 |
Why?
|
Electronic Health Records | 16 | 2024 | 4775 | 1.200 |
Why?
|
Disclosure | 7 | 2022 | 738 | 1.140 |
Why?
|
Bioethical Issues | 2 | 2017 | 121 | 1.030 |
Why?
|
Rare Diseases | 6 | 2023 | 619 | 0.930 |
Why?
|
Research Subjects | 4 | 2018 | 249 | 0.880 |
Why?
|
Comprehension | 4 | 2017 | 617 | 0.860 |
Why?
|
Confidentiality | 3 | 2019 | 609 | 0.850 |
Why?
|
Patient Preference | 4 | 2018 | 922 | 0.770 |
Why?
|
Genetic Counseling | 6 | 2024 | 624 | 0.740 |
Why?
|
Death, Sudden | 3 | 2022 | 302 | 0.670 |
Why?
|
Genetic Privacy | 3 | 2017 | 60 | 0.650 |
Why?
|
Genetics, Medical | 6 | 2019 | 336 | 0.630 |
Why?
|
Databases, Genetic | 7 | 2017 | 1738 | 0.620 |
Why?
|
Genetic Diseases, Inborn | 3 | 2021 | 601 | 0.610 |
Why?
|
Attitude to Health | 4 | 2019 | 2029 | 0.600 |
Why?
|
Truth Disclosure | 2 | 2019 | 432 | 0.600 |
Why?
|
Family | 5 | 2021 | 3189 | 0.550 |
Why?
|
Depression, Postpartum | 1 | 2021 | 345 | 0.550 |
Why?
|
Population Groups | 6 | 2023 | 211 | 0.530 |
Why?
|
Cryopyrin-Associated Periodic Syndromes | 1 | 2015 | 17 | 0.520 |
Why?
|
Genes, BRCA2 | 1 | 2019 | 603 | 0.510 |
Why?
|
Biomedical Research | 8 | 2018 | 3426 | 0.490 |
Why?
|
Personal Satisfaction | 2 | 2018 | 643 | 0.480 |
Why?
|
Genome, Human | 11 | 2024 | 4418 | 0.480 |
Why?
|
Vitamin D Deficiency | 3 | 2021 | 1379 | 0.470 |
Why?
|
Hypophosphatemia, Familial | 3 | 2001 | 32 | 0.470 |
Why?
|
Decision Making | 6 | 2022 | 3925 | 0.470 |
Why?
|
Child | 58 | 2023 | 79799 | 0.460 |
Why?
|
Arm Injuries | 1 | 2015 | 156 | 0.460 |
Why?
|
Physical Fitness | 2 | 2014 | 732 | 0.440 |
Why?
|
Public Opinion | 1 | 2017 | 481 | 0.420 |
Why?
|
Orthopedics | 1 | 2021 | 892 | 0.420 |
Why?
|
Conditioning, Classical | 1 | 2015 | 364 | 0.420 |
Why?
|
Infant, Newborn | 27 | 2024 | 26179 | 0.420 |
Why?
|
Hand Injuries | 1 | 2015 | 239 | 0.420 |
Why?
|
Age of Onset | 2 | 2019 | 3302 | 0.410 |
Why?
|
Sudden Infant Death | 4 | 2020 | 291 | 0.410 |
Why?
|
Medical History Taking | 1 | 2016 | 773 | 0.410 |
Why?
|
Exercise Therapy | 2 | 2020 | 919 | 0.400 |
Why?
|
Musculoskeletal Diseases | 2 | 2014 | 595 | 0.390 |
Why?
|
Genetic Predisposition to Disease | 14 | 2024 | 17790 | 0.380 |
Why?
|
Seizures, Febrile | 1 | 2012 | 108 | 0.370 |
Why?
|
Humans | 146 | 2024 | 760613 | 0.370 |
Why?
|
Sequence Analysis, DNA | 8 | 2019 | 4716 | 0.350 |
Why?
|
Health Education | 3 | 2024 | 1049 | 0.330 |
Why?
|
Cerebral Palsy | 2 | 2004 | 471 | 0.310 |
Why?
|
Guidelines as Topic | 2 | 2014 | 1392 | 0.300 |
Why?
|
Culture | 1 | 2012 | 622 | 0.300 |
Why?
|
Adult | 58 | 2024 | 220007 | 0.300 |
Why?
|
Child, Preschool | 27 | 2022 | 42056 | 0.290 |
Why?
|
Female | 82 | 2024 | 391246 | 0.290 |
Why?
|
Motivation | 3 | 2022 | 1993 | 0.280 |
Why?
|
Pediatrics | 6 | 2022 | 3586 | 0.280 |
Why?
|
Sleep | 1 | 2022 | 4750 | 0.280 |
Why?
|
Immunoglobulin Fc Fragments | 2 | 2019 | 280 | 0.270 |
Why?
|
Cytochrome P-450 CYP2D6 | 2 | 2017 | 105 | 0.270 |
Why?
|
Bone Development | 2 | 2007 | 472 | 0.270 |
Why?
|
Pedigree | 4 | 2012 | 4578 | 0.270 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3448 | 0.270 |
Why?
|
Parental Consent | 2 | 2018 | 63 | 0.270 |
Why?
|
Male | 75 | 2024 | 359718 | 0.270 |
Why?
|
Genetic Variation | 6 | 2019 | 6552 | 0.260 |
Why?
|
Replication Protein C | 1 | 2024 | 25 | 0.240 |
Why?
|
Models, Theoretical | 1 | 2017 | 3562 | 0.240 |
Why?
|
Language Development Disorders | 2 | 2020 | 192 | 0.240 |
Why?
|
Axoneme | 1 | 2024 | 22 | 0.240 |
Why?
|
Acidosis, Lactic | 2 | 2015 | 145 | 0.230 |
Why?
|
Ethics Committees, Research | 4 | 2023 | 196 | 0.230 |
Why?
|
Ciliary Motility Disorders | 1 | 2024 | 51 | 0.230 |
Why?
|
Centrioles | 1 | 2024 | 79 | 0.230 |
Why?
|
Graves Disease | 1 | 2005 | 239 | 0.220 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4744 | 0.220 |
Why?
|
Chondroitinsulfatases | 1 | 2023 | 16 | 0.220 |
Why?
|
Walking | 2 | 2014 | 1190 | 0.210 |
Why?
|
National Human Genome Research Institute (U.S.) | 3 | 2016 | 22 | 0.210 |
Why?
|
Infant | 22 | 2024 | 36053 | 0.210 |
Why?
|
Adolescent | 34 | 2022 | 87809 | 0.210 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2019 | 3617 | 0.200 |
Why?
|
Research Design | 1 | 2018 | 6180 | 0.200 |
Why?
|
Genome-Wide Association Study | 4 | 2024 | 12628 | 0.200 |
Why?
|
Child Development Disorders, Pervasive | 3 | 2012 | 599 | 0.200 |
Why?
|
Gait Disorders, Neurologic | 1 | 2004 | 238 | 0.200 |
Why?
|
Locomotion | 1 | 2004 | 387 | 0.190 |
Why?
|
Vital Statistics | 1 | 2021 | 31 | 0.190 |
Why?
|
Osteoarthritis, Knee | 3 | 2020 | 1234 | 0.190 |
Why?
|
Health Status | 1 | 2014 | 4082 | 0.190 |
Why?
|
Arthralgia | 3 | 2016 | 461 | 0.190 |
Why?
|
Hospitals, Pediatric | 3 | 2016 | 1854 | 0.190 |
Why?
|
Immunoglobulin G | 3 | 2019 | 4542 | 0.180 |
Why?
|
Alcohol Drinking | 2 | 2021 | 4013 | 0.180 |
Why?
|
Blepharophimosis | 1 | 2020 | 21 | 0.180 |
Why?
|
Tubulin | 1 | 2024 | 692 | 0.180 |
Why?
|
Pharmacogenetics | 4 | 2019 | 680 | 0.170 |
Why?
|
Pyrophosphatases | 1 | 2020 | 139 | 0.170 |
Why?
|
Patient Access to Records | 2 | 2014 | 119 | 0.170 |
Why?
|
Phenotype | 14 | 2024 | 16548 | 0.170 |
Why?
|
Cilia | 1 | 2024 | 493 | 0.170 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 2013 | 0.170 |
Why?
|
Mutation | 12 | 2024 | 29957 | 0.170 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2020 | 199 | 0.170 |
Why?
|
Personal Autonomy | 2 | 2019 | 302 | 0.170 |
Why?
|
Bone Diseases | 4 | 2009 | 418 | 0.160 |
Why?
|
Multifactorial Inheritance | 2 | 2024 | 1365 | 0.160 |
Why?
|
National Institutes of Health (U.S.) | 3 | 2017 | 791 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
Patient Rights | 2 | 2016 | 125 | 0.160 |
Why?
|
Communication | 4 | 2024 | 3849 | 0.160 |
Why?
|
Thalassemia | 2 | 2009 | 270 | 0.150 |
Why?
|
Boston | 4 | 2016 | 9278 | 0.150 |
Why?
|
Frameshift Mutation | 1 | 2020 | 388 | 0.150 |
Why?
|
Sodium Channels | 1 | 2020 | 344 | 0.150 |
Why?
|
Stillbirth | 1 | 2021 | 367 | 0.150 |
Why?
|
Censuses | 1 | 2019 | 201 | 0.150 |
Why?
|
Adenosylmethionine Decarboxylase | 3 | 1995 | 11 | 0.150 |
Why?
|
Proteins | 4 | 2001 | 6029 | 0.150 |
Why?
|
Middle Aged | 28 | 2023 | 220359 | 0.150 |
Why?
|
Binding Sites, Antibody | 1 | 2017 | 337 | 0.150 |
Why?
|
Vocabulary | 1 | 2018 | 165 | 0.150 |
Why?
|
Bone and Bones | 2 | 2009 | 2560 | 0.140 |
Why?
|
Duty to Recontact | 1 | 2016 | 19 | 0.140 |
Why?
|
Diagnosis | 1 | 2018 | 157 | 0.140 |
Why?
|
United States | 17 | 2021 | 72448 | 0.140 |
Why?
|
Pregnant Women | 1 | 2021 | 563 | 0.140 |
Why?
|
Congenital Abnormalities | 1 | 2021 | 704 | 0.130 |
Why?
|
Infant Mortality | 1 | 2021 | 756 | 0.130 |
Why?
|
Tooth Eruption | 1 | 1995 | 29 | 0.130 |
Why?
|
Immersion | 1 | 2015 | 36 | 0.130 |
Why?
|
Dental Pulp Cavity | 1 | 1995 | 35 | 0.130 |
Why?
|
Informed Consent By Minors | 1 | 2015 | 9 | 0.130 |
Why?
|
Cytochrome Reductases | 1 | 2015 | 9 | 0.130 |
Why?
|
Health | 1 | 2019 | 396 | 0.130 |
Why?
|
Craniofacial Abnormalities | 1 | 2018 | 315 | 0.130 |
Why?
|
Tooth Abnormalities | 1 | 1995 | 56 | 0.130 |
Why?
|
Anticipation, Psychological | 1 | 2016 | 85 | 0.130 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 1996 | 120 | 0.130 |
Why?
|
Publications | 1 | 2018 | 194 | 0.130 |
Why?
|
Rewarming | 1 | 2015 | 64 | 0.130 |
Why?
|
Metabolic Equivalent | 1 | 2014 | 14 | 0.130 |
Why?
|
Immunity, Humoral | 1 | 2019 | 604 | 0.120 |
Why?
|
Adaptation, Psychological | 3 | 2018 | 2628 | 0.120 |
Why?
|
GTPase-Activating Proteins | 1 | 2018 | 475 | 0.120 |
Why?
|
Mitochondria, Muscle | 1 | 1996 | 172 | 0.120 |
Why?
|
Professional Role | 1 | 2018 | 310 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1229 | 0.120 |
Why?
|
Privacy | 1 | 2017 | 233 | 0.120 |
Why?
|
Genetics | 1 | 2015 | 114 | 0.120 |
Why?
|
Data Collection | 2 | 2014 | 3315 | 0.120 |
Why?
|
Sequence Deletion | 2 | 2013 | 1493 | 0.120 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1996 | 618 | 0.120 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2013 | 24 | 0.120 |
Why?
|
Carney Complex | 1 | 2013 | 15 | 0.110 |
Why?
|
Receptors, Fc | 1 | 2017 | 534 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2019 | 1832 | 0.110 |
Why?
|
Liver Function Tests | 1 | 2015 | 524 | 0.110 |
Why?
|
Oxidative Phosphorylation | 1 | 1996 | 495 | 0.110 |
Why?
|
Down Syndrome | 1 | 2022 | 892 | 0.110 |
Why?
|
Concept Formation | 1 | 2015 | 159 | 0.110 |
Why?
|
Exons | 5 | 2020 | 2389 | 0.110 |
Why?
|
Uncertainty | 2 | 2018 | 754 | 0.110 |
Why?
|
Neoplasms, Connective Tissue | 1 | 2013 | 36 | 0.110 |
Why?
|
Life Style | 1 | 2005 | 3898 | 0.110 |
Why?
|
Autopsy | 2 | 2020 | 1007 | 0.110 |
Why?
|
Ethics, Research | 1 | 2015 | 176 | 0.110 |
Why?
|
Disease | 1 | 2019 | 671 | 0.110 |
Why?
|
PHEX Phosphate Regulating Neutral Endopeptidase | 4 | 2001 | 17 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2022 | 2896 | 0.110 |
Why?
|
Autistic Disorder | 3 | 2013 | 1214 | 0.110 |
Why?
|
Vitamins | 1 | 2021 | 1634 | 0.110 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 192 | 0.110 |
Why?
|
Body Mass Index | 2 | 2014 | 12914 | 0.110 |
Why?
|
Societies, Scientific | 1 | 2014 | 221 | 0.110 |
Why?
|
Access to Information | 1 | 2016 | 320 | 0.110 |
Why?
|
Laboratories | 1 | 2016 | 462 | 0.110 |
Why?
|
Young Adult | 13 | 2017 | 58748 | 0.100 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1344 | 0.100 |
Why?
|
Cataract | 2 | 2015 | 827 | 0.100 |
Why?
|
Rett Syndrome | 1 | 2014 | 164 | 0.100 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2013 | 419 | 0.100 |
Why?
|
Incidental Findings | 2 | 2016 | 698 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2020 | 1572 | 0.100 |
Why?
|
Cold Temperature | 1 | 2015 | 780 | 0.100 |
Why?
|
Knee Injuries | 2 | 2010 | 489 | 0.100 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 496 | 0.100 |
Why?
|
Risk Assessment | 7 | 2024 | 24102 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2023 | 1951 | 0.100 |
Why?
|
Enchondromatosis | 1 | 2011 | 14 | 0.100 |
Why?
|
Growth Disorders | 3 | 2009 | 653 | 0.100 |
Why?
|
Mitochondrial Diseases | 1 | 2015 | 340 | 0.100 |
Why?
|
Exostoses, Multiple Hereditary | 1 | 2011 | 29 | 0.100 |
Why?
|
Osteotomy | 2 | 1994 | 836 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9591 | 0.090 |
Why?
|
Patient Participation | 2 | 2018 | 1439 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2014 | 340 | 0.090 |
Why?
|
Psychiatry | 1 | 2023 | 1689 | 0.090 |
Why?
|
Models, Psychological | 1 | 2015 | 827 | 0.090 |
Why?
|
Mothers | 1 | 2021 | 2186 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3725 | 0.090 |
Why?
|
Child Welfare | 1 | 2014 | 516 | 0.090 |
Why?
|
Femur | 2 | 1994 | 1302 | 0.090 |
Why?
|
Pilot Projects | 3 | 2018 | 8556 | 0.090 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2011 | 224 | 0.090 |
Why?
|
Pyruvates | 1 | 1989 | 84 | 0.090 |
Why?
|
Patient Selection | 2 | 2019 | 4279 | 0.090 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5795 | 0.090 |
Why?
|
Carboxy-Lyases | 1 | 1989 | 85 | 0.080 |
Why?
|
Enzyme Precursors | 1 | 1989 | 174 | 0.080 |
Why?
|
Glycosylation | 3 | 2019 | 1096 | 0.080 |
Why?
|
Muscle Contraction | 2 | 1994 | 1201 | 0.080 |
Why?
|
Vitamin D | 2 | 2021 | 3291 | 0.080 |
Why?
|
Developmental Disabilities | 1 | 2018 | 1504 | 0.080 |
Why?
|
Documentation | 1 | 2015 | 893 | 0.080 |
Why?
|
Norway | 3 | 2014 | 496 | 0.080 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2010 | 342 | 0.080 |
Why?
|
Follow-Up Studies | 9 | 2020 | 39262 | 0.080 |
Why?
|
Tissue Donors | 1 | 2018 | 2314 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.080 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2021 | 2496 | 0.080 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2010 | 324 | 0.080 |
Why?
|
INDEL Mutation | 1 | 2009 | 266 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2024 | 10343 | 0.080 |
Why?
|
Blood Pressure | 1 | 2024 | 8525 | 0.080 |
Why?
|
Language | 1 | 2018 | 1533 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2018 | 12968 | 0.080 |
Why?
|
Smoking | 1 | 2005 | 9073 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3310 | 0.080 |
Why?
|
Age Factors | 6 | 2019 | 18413 | 0.070 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3865 | 0.070 |
Why?
|
Activities of Daily Living | 2 | 2014 | 2417 | 0.070 |
Why?
|
Postpartum Period | 1 | 2014 | 1168 | 0.070 |
Why?
|
Osteomalacia | 2 | 2013 | 56 | 0.070 |
Why?
|
Osteochondrodysplasias | 1 | 2009 | 182 | 0.070 |
Why?
|
Practice Guidelines as Topic | 4 | 2019 | 7475 | 0.070 |
Why?
|
TRPV Cation Channels | 1 | 2009 | 243 | 0.070 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2011 | 378 | 0.070 |
Why?
|
Densitometry | 1 | 2007 | 151 | 0.070 |
Why?
|
Aged | 16 | 2023 | 169143 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2015 | 1741 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1652 | 0.070 |
Why?
|
Hypothermia | 1 | 1988 | 188 | 0.070 |
Why?
|
Mutation, Missense | 2 | 2009 | 2567 | 0.070 |
Why?
|
Vesicular Transport Proteins | 1 | 2009 | 374 | 0.070 |
Why?
|
Genetic Linkage | 3 | 2011 | 2381 | 0.070 |
Why?
|
Focus Groups | 1 | 2012 | 1378 | 0.070 |
Why?
|
Bone Neoplasms | 2 | 2013 | 2531 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 1928 | 0.070 |
Why?
|
Exercise Test | 1 | 2014 | 2128 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2010 | 1387 | 0.060 |
Why?
|
Oxymetazoline | 1 | 1985 | 5 | 0.060 |
Why?
|
Motor Activity | 2 | 2014 | 2688 | 0.060 |
Why?
|
Endocrine System Diseases | 1 | 2008 | 250 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2024 | 15790 | 0.060 |
Why?
|
Qualitative Research | 1 | 2016 | 2963 | 0.060 |
Why?
|
Phosphates | 2 | 2001 | 772 | 0.060 |
Why?
|
Bone Density | 3 | 2009 | 3534 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3258 | 0.060 |
Why?
|
Research Personnel | 2 | 2023 | 582 | 0.060 |
Why?
|
Cohort Studies | 8 | 2024 | 41337 | 0.060 |
Why?
|
Genetic Loci | 1 | 2013 | 2618 | 0.060 |
Why?
|
Calcium-Binding Proteins | 1 | 2009 | 1067 | 0.060 |
Why?
|
X Chromosome | 2 | 1998 | 815 | 0.060 |
Why?
|
Emotions | 1 | 2016 | 2734 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8803 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21029 | 0.060 |
Why?
|
Minority Groups | 2 | 2023 | 1201 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3985 | 0.060 |
Why?
|
Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.060 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2024 | 283 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2653 | 0.060 |
Why?
|
Hospitals | 1 | 2017 | 3928 | 0.050 |
Why?
|
Self Report | 1 | 2014 | 3711 | 0.050 |
Why?
|
Mental Disorders | 1 | 2023 | 6796 | 0.050 |
Why?
|
Risk Factors | 7 | 2024 | 74333 | 0.050 |
Why?
|
Hormones | 1 | 2007 | 867 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7805 | 0.050 |
Why?
|
Primary Health Care | 2 | 2018 | 4647 | 0.050 |
Why?
|
Introns | 3 | 2009 | 978 | 0.050 |
Why?
|
Hamartoma Syndrome, Multiple | 1 | 2004 | 114 | 0.050 |
Why?
|
Knee Joint | 3 | 2016 | 1663 | 0.050 |
Why?
|
Diphosphonates | 1 | 2007 | 638 | 0.050 |
Why?
|
Siblings | 2 | 2019 | 824 | 0.050 |
Why?
|
Prospective Studies | 7 | 2023 | 54306 | 0.050 |
Why?
|
North Dakota | 1 | 2021 | 14 | 0.050 |
Why?
|
Radiography | 4 | 2016 | 6965 | 0.050 |
Why?
|
South Dakota | 1 | 2021 | 32 | 0.050 |
Why?
|
Antiporters | 1 | 2023 | 278 | 0.050 |
Why?
|
Endocrinology | 1 | 2008 | 443 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4878 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 1989 | 1974 | 0.050 |
Why?
|
Depression | 1 | 2021 | 8045 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2010 | 4286 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2001 | 4108 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2023 | 440 | 0.050 |
Why?
|
Genotype | 4 | 2015 | 12957 | 0.050 |
Why?
|
Tooth Diseases | 1 | 2001 | 74 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3763 | 0.050 |
Why?
|
Forecasting | 2 | 2021 | 2931 | 0.050 |
Why?
|
Genetic Association Studies | 3 | 2015 | 2716 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4626 | 0.050 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 1998 | 330 | 0.040 |
Why?
|
Hyperplasia | 1 | 2004 | 1155 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 1988 | 1174 | 0.040 |
Why?
|
Nuclear Family | 1 | 2001 | 313 | 0.040 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2004 | 325 | 0.040 |
Why?
|
Athletic Injuries | 1 | 2010 | 1209 | 0.040 |
Why?
|
Osteophyte | 1 | 2020 | 44 | 0.040 |
Why?
|
Physicians | 1 | 2018 | 4591 | 0.040 |
Why?
|
Anxiety | 1 | 2015 | 4538 | 0.040 |
Why?
|
Glycogen Storage Disease | 1 | 1999 | 41 | 0.040 |
Why?
|
Microarray Analysis | 2 | 2015 | 747 | 0.040 |
Why?
|
Chronic Disease | 1 | 2014 | 9288 | 0.040 |
Why?
|
Facies | 1 | 2020 | 223 | 0.040 |
Why?
|
Algorithms | 2 | 2019 | 13982 | 0.040 |
Why?
|
Physical Therapy Modalities | 2 | 2020 | 536 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2024 | 1697 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1722 | 0.040 |
Why?
|
Brain Diseases | 1 | 1988 | 1540 | 0.040 |
Why?
|
Retrospective Studies | 3 | 2021 | 80345 | 0.040 |
Why?
|
Imidazoles | 1 | 1985 | 1180 | 0.040 |
Why?
|
Escherichia coli | 2 | 1995 | 4219 | 0.040 |
Why?
|
Odds Ratio | 2 | 2014 | 9716 | 0.040 |
Why?
|
Syndrome | 2 | 2018 | 3280 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2015 | 22052 | 0.040 |
Why?
|
Symporters | 1 | 2001 | 361 | 0.040 |
Why?
|
Histone Acetyltransferases | 1 | 2020 | 337 | 0.040 |
Why?
|
HeLa Cells | 1 | 2024 | 3105 | 0.040 |
Why?
|
Hypophosphatemia | 1 | 1998 | 93 | 0.040 |
Why?
|
Thigh | 2 | 2001 | 240 | 0.040 |
Why?
|
Abnormalities, Multiple | 1 | 1985 | 1415 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2021 | 14494 | 0.040 |
Why?
|
Harm Reduction | 1 | 2019 | 145 | 0.040 |
Why?
|
Tendons | 1 | 2001 | 552 | 0.040 |
Why?
|
DNA Replication | 1 | 2024 | 1412 | 0.040 |
Why?
|
Anticonvulsants | 1 | 2007 | 1879 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2021 | 758 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2001 | 1737 | 0.030 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 63 | 0.030 |
Why?
|
Cytogenetics | 1 | 1997 | 198 | 0.030 |
Why?
|
Parenting | 1 | 2022 | 695 | 0.030 |
Why?
|
Base Sequence | 4 | 2017 | 12444 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2018 | 225 | 0.030 |
Why?
|
Pregnancy | 3 | 2024 | 29746 | 0.030 |
Why?
|
Tooth Eruption, Ectopic | 1 | 1995 | 6 | 0.030 |
Why?
|
Human Rights | 1 | 2019 | 306 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2016 | 240 | 0.030 |
Why?
|
Odontometry | 1 | 1995 | 29 | 0.030 |
Why?
|
Disease Management | 2 | 2018 | 2514 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1821 | 0.030 |
Why?
|
Employment | 1 | 2002 | 1112 | 0.030 |
Why?
|
Morocco | 1 | 2015 | 30 | 0.030 |
Why?
|
Cuspid | 1 | 1995 | 55 | 0.030 |
Why?
|
Nurses | 1 | 2005 | 2467 | 0.030 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2015 | 32 | 0.030 |
Why?
|
Quality of Life | 2 | 2014 | 13308 | 0.030 |
Why?
|
Serotonin | 2 | 2010 | 1040 | 0.030 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 1997 | 311 | 0.030 |
Why?
|
Sex Ratio | 1 | 1995 | 107 | 0.030 |
Why?
|
Metalloendopeptidases | 1 | 1997 | 393 | 0.030 |
Why?
|
Disease Progression | 2 | 2020 | 13505 | 0.030 |
Why?
|
Glucuronosyltransferase | 1 | 2015 | 130 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12159 | 0.030 |
Why?
|
Databases, Factual | 1 | 2010 | 8022 | 0.030 |
Why?
|
Ankle Injuries | 1 | 1999 | 334 | 0.030 |
Why?
|
Sex Factors | 2 | 2014 | 10546 | 0.030 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1996 | 412 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2014 | 25941 | 0.030 |
Why?
|
Waiting Lists | 1 | 1999 | 763 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 1997 | 4169 | 0.030 |
Why?
|
Recombinant Proteins | 3 | 2014 | 6538 | 0.030 |
Why?
|
Database Management Systems | 1 | 2015 | 258 | 0.030 |
Why?
|
Spinal Diseases | 1 | 1999 | 559 | 0.030 |
Why?
|
Tooth | 1 | 1995 | 208 | 0.030 |
Why?
|
Health Surveys | 1 | 2004 | 4063 | 0.030 |
Why?
|
Knowledge Bases | 1 | 2014 | 98 | 0.030 |
Why?
|
Leg Length Inequality | 1 | 1994 | 56 | 0.030 |
Why?
|
Bilirubin | 1 | 2015 | 438 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2023 | 2255 | 0.030 |
Why?
|
RNA Splicing | 1 | 2018 | 915 | 0.030 |
Why?
|
Research Report | 1 | 2016 | 370 | 0.030 |
Why?
|
Clinical Trials as Topic | 3 | 2016 | 8055 | 0.030 |
Why?
|
Sample Size | 1 | 2016 | 840 | 0.030 |
Why?
|
Myopathies, Structural, Congenital | 1 | 2014 | 103 | 0.030 |
Why?
|
Consanguinity | 1 | 2015 | 456 | 0.030 |
Why?
|
Prevalence | 3 | 2021 | 15686 | 0.030 |
Why?
|
Gene Frequency | 2 | 2010 | 3613 | 0.030 |
Why?
|
Alleles | 1 | 2024 | 6900 | 0.030 |
Why?
|
Adenoma | 1 | 2004 | 2148 | 0.030 |
Why?
|
Mice, Knockout | 2 | 2024 | 14374 | 0.030 |
Why?
|
Biological Transport | 1 | 1997 | 2086 | 0.030 |
Why?
|
Financing, Organized | 1 | 2014 | 204 | 0.030 |
Why?
|
Logistic Models | 2 | 2009 | 13312 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2015 | 865 | 0.030 |
Why?
|
Professional-Family Relations | 1 | 2016 | 495 | 0.030 |
Why?
|
Polyamines | 1 | 1992 | 133 | 0.030 |
Why?
|
Patients | 1 | 2018 | 906 | 0.030 |
Why?
|
Paraneoplastic Syndromes | 1 | 2013 | 155 | 0.020 |
Why?
|
Heterozygote | 1 | 2019 | 2798 | 0.020 |
Why?
|
Software | 2 | 2016 | 4419 | 0.020 |
Why?
|
Linear Models | 2 | 2014 | 5877 | 0.020 |
Why?
|
Penetrance | 1 | 2013 | 388 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1180 | 0.020 |
Why?
|
Absorptiometry, Photon | 2 | 2009 | 1736 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.020 |
Why?
|
Food, Fortified | 1 | 1992 | 189 | 0.020 |
Why?
|
Perception | 1 | 2017 | 1195 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1650 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2907 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2015 | 1996 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2004 | 2332 | 0.020 |
Why?
|
Health Promotion | 1 | 2022 | 2207 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2017 | 833 | 0.020 |
Why?
|
Survivors | 1 | 2020 | 2375 | 0.020 |
Why?
|
Specimen Handling | 1 | 2014 | 707 | 0.020 |
Why?
|
DNA Primers | 2 | 2009 | 2818 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3164 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1997 | 1613 | 0.020 |
Why?
|
Spinal Fusion | 1 | 1999 | 1281 | 0.020 |
Why?
|
Muscle Strength | 1 | 2014 | 619 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1989 | 418 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 1975 | 0.020 |
Why?
|
Enzyme Induction | 1 | 1989 | 452 | 0.020 |
Why?
|
Milk | 1 | 1992 | 443 | 0.020 |
Why?
|
Animals | 7 | 2024 | 167960 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 1995 | 3465 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 2011 | 442 | 0.020 |
Why?
|
History, 21st Century | 1 | 2015 | 1575 | 0.020 |
Why?
|
Somatomedins | 1 | 2009 | 178 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 659 | 0.020 |
Why?
|
Sports | 1 | 1995 | 700 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2557 | 0.020 |
Why?
|
Medulla Oblongata | 1 | 2009 | 248 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1500 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2852 | 0.020 |
Why?
|
Karyotyping | 1 | 2010 | 1172 | 0.020 |
Why?
|
Counseling | 1 | 2015 | 1548 | 0.020 |
Why?
|
Tibia | 1 | 2013 | 1065 | 0.020 |
Why?
|
Hippocampus | 1 | 2020 | 3738 | 0.020 |
Why?
|
Joints | 1 | 2009 | 321 | 0.020 |
Why?
|
History, 20th Century | 1 | 2015 | 2773 | 0.020 |
Why?
|
Growth Hormone | 1 | 2009 | 568 | 0.020 |
Why?
|
Incidence | 1 | 2005 | 21391 | 0.020 |
Why?
|
Reference Values | 1 | 2014 | 4925 | 0.020 |
Why?
|
California | 1 | 2010 | 1416 | 0.020 |
Why?
|
Ferritins | 1 | 2009 | 598 | 0.020 |
Why?
|
Mice | 3 | 2024 | 81209 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2698 | 0.020 |
Why?
|
Genes | 1 | 1989 | 1845 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 2913 | 0.020 |
Why?
|
Body Height | 1 | 1992 | 1570 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5325 | 0.020 |
Why?
|
Muscle, Skeletal | 2 | 2001 | 4924 | 0.020 |
Why?
|
Bone Remodeling | 1 | 2009 | 580 | 0.020 |
Why?
|
Medical Records | 1 | 2010 | 1407 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2009 | 6065 | 0.010 |
Why?
|
Plasmids | 1 | 1989 | 2275 | 0.010 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15840 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3774 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4122 | 0.010 |
Why?
|
Social Behavior | 1 | 2010 | 1131 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2009 | 1091 | 0.010 |
Why?
|
Organ Size | 1 | 2009 | 2254 | 0.010 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2005 | 363 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2009 | 12762 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2668 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2764 | 0.010 |
Why?
|
Exercise | 2 | 1999 | 5787 | 0.010 |
Why?
|
Hypogonadism | 1 | 2009 | 801 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2893 | 0.010 |
Why?
|
Parathyroid Hormone | 1 | 2009 | 1797 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
Calcitonin | 1 | 2004 | 330 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20080 | 0.010 |
Why?
|
Spinal Fractures | 1 | 2009 | 702 | 0.010 |
Why?
|
Kinetics | 1 | 1989 | 6377 | 0.010 |
Why?
|
Mitochondria | 1 | 2015 | 3601 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 413 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4571 | 0.010 |
Why?
|
Sodium-Phosphate Cotransporter Proteins, Type II | 1 | 2001 | 1 | 0.010 |
Why?
|
Sodium-Phosphate Cotransporter Proteins | 1 | 2001 | 7 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10553 | 0.010 |
Why?
|
Cytochalasin D | 1 | 2001 | 91 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 1995 | 17624 | 0.010 |
Why?
|
Gene Expression | 2 | 1995 | 7587 | 0.010 |
Why?
|
Medical Records Systems, Computerized | 1 | 2007 | 1191 | 0.010 |
Why?
|
Cycloheximide | 1 | 2001 | 343 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15286 | 0.010 |
Why?
|
Glycogen Debranching Enzyme System | 1 | 1999 | 5 | 0.010 |
Why?
|
Phosphorylase Kinase | 1 | 1999 | 9 | 0.010 |
Why?
|
Phosphorylases | 1 | 1999 | 17 | 0.010 |
Why?
|
Glycogen Synthase | 1 | 1999 | 62 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1997 | 7850 | 0.010 |
Why?
|
Rupture | 1 | 2001 | 443 | 0.010 |
Why?
|
Calcium | 2 | 2009 | 5725 | 0.010 |
Why?
|
Pain | 2 | 2009 | 5066 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 522 | 0.010 |
Why?
|
Colchicine | 1 | 2001 | 261 | 0.010 |
Why?
|
Range of Motion, Articular | 2 | 1999 | 1583 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2023 | 58980 | 0.010 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 1999 | 94 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6359 | 0.010 |
Why?
|
Liver | 1 | 1995 | 7510 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1115 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4673 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 36286 | 0.010 |
Why?
|
Thyroid Gland | 1 | 2004 | 1168 | 0.010 |
Why?
|
Weight-Bearing | 1 | 1999 | 518 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9406 | 0.010 |
Why?
|
Recurrence | 1 | 1988 | 8483 | 0.010 |
Why?
|
Sex Differentiation | 1 | 1996 | 73 | 0.010 |
Why?
|
Anterior Cruciate Ligament | 1 | 1999 | 423 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1998 | 13451 | 0.010 |
Why?
|
Internet | 1 | 2007 | 3078 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1995 | 1055 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2802 | 0.010 |
Why?
|
Spermine Synthase | 1 | 1992 | 2 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2001 | 6130 | 0.010 |
Why?
|
Eflornithine | 1 | 1992 | 31 | 0.010 |
Why?
|
Point Mutation | 1 | 1998 | 1594 | 0.010 |
Why?
|
Spermidine | 1 | 1992 | 61 | 0.010 |
Why?
|
Spermine | 1 | 1992 | 69 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 783 | 0.010 |
Why?
|
Diamines | 1 | 1992 | 59 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10755 | 0.010 |
Why?
|
Disability Evaluation | 1 | 1999 | 1826 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1995 | 814 | 0.010 |
Why?
|
Ergocalciferols | 1 | 1992 | 110 | 0.010 |
Why?
|
Calcifediol | 1 | 1992 | 161 | 0.010 |
Why?
|
Bone Nails | 1 | 1992 | 218 | 0.010 |
Why?
|
Neurons | 1 | 2009 | 9424 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2016 | 15760 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2004 | 11070 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 12102 | 0.010 |
Why?
|
CHO Cells | 1 | 1992 | 1389 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 1995 | 7593 | 0.010 |
Why?
|
Aging | 1 | 2009 | 8652 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18137 | 0.010 |
Why?
|
Disabled Persons | 1 | 1999 | 1223 | 0.010 |
Why?
|
Hypercalcemia | 1 | 1992 | 421 | 0.010 |
Why?
|
Bone Plates | 1 | 1992 | 465 | 0.010 |
Why?
|
Cricetinae | 1 | 1992 | 2427 | 0.010 |
Why?
|
Spleen | 1 | 1995 | 2298 | 0.000 |
Why?
|
Heart Massage | 1 | 1968 | 31 | 0.000 |
Why?
|
Carrier Proteins | 1 | 2001 | 4938 | 0.000 |
Why?
|
Cholecalciferol | 1 | 1992 | 550 | 0.000 |
Why?
|
Kidney | 1 | 2001 | 7064 | 0.000 |
Why?
|
Hip Joint | 1 | 1992 | 1006 | 0.000 |
Why?
|
Transfection | 1 | 1992 | 5781 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2005 | 20509 | 0.000 |
Why?
|
Prognosis | 2 | 1999 | 29661 | 0.000 |
Why?
|
Rats | 1 | 1995 | 23709 | 0.000 |
Why?
|
Heart Arrest | 1 | 1968 | 1506 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1992 | 18955 | 0.000 |
Why?
|
Stress, Psychological | 1 | 1992 | 4446 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 1992 | 11902 | 0.000 |
Why?
|
Diet | 1 | 1992 | 8010 | 0.000 |
Why?
|
Treatment Outcome | 1 | 1999 | 64981 | 0.000 |
Why?
|
Hypoxia, Brain | 1 | 1968 | 138 | 0.000 |
Why?
|
Electric Countershock | 1 | 1968 | 537 | 0.000 |
Why?
|
Respiration, Artificial | 1 | 1968 | 2622 | 0.000 |
Why?
|